CD40 agonist mAb administration activates TAMs.[37] Our study demonstrates that CD40 delivery via either IP or NDES significantly skews macrophages toward a M1 phenotypic response within the tumor after 14 days (Figure 3C,D). This evidence concerns the gene CD40 and neoplasm.